Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Treg cells help repair and regenerate tissues by interacting with local cells.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Older skin has higher cancer risk due to inflammation and stem cell issues.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Early regulatory T cells are crucial for normal skin pigmentation.

Mint water extract boosts protective enzymes in skin cells.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Maintaining DNA integrity in stem cells is crucial to prevent aging and cancer.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Modulating the BTNL2 pathway can prevent hair loss in mice.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.